News | February 20, 2025
Innocan Pharma granted first patent in India for its Liposomal CBD Injection
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
ForDoz Pharma Corporation, USA (ForDoz) received an approval for its ANDA from the USFDA
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Silo enters into commercial evaluation license agreement for next generation liposomes
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides
Subscribe To Our Newsletter & Stay Updated
